Claro Pharmaceuticals Private Limited

Claro Pharmaceuticals Private Limited - healthcare in Hyderabad, Telangana, India. FY 2026 financials & compliance.
CIN U24232TG2011PTC073540 Incorporated 28 March 2011 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company healthcare
Data last updated
Revenue · FY 2020
₹37.41 Lakh
▲ 5% YoY
Net loss · FY 2020
₹5,616
Net margin -0.2%
EBITDA · FY 2020
₹24,928
EBITDA margin 0.7%
Authorised capital
₹20 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered

About Claro Pharmaceuticals Private Limited

Data last updated:

Claro Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 28 March 2011 and has been in existence for over 15 years.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2011PTC073540. Its GSTIN is 36AAECC4747M1ZA (Telangana).

The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Chevuru Hariprasad and Arun Singh.

Its last annual general meeting (AGM) was held on 31 December 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office is at 16 – 2 – 753/1/192 Konark Towers Flat No. 405 Gaddi Annaram, Hyderabad, Telangana, India – 500035.

As per the financials filed for FY 2020, the company reported a revenue of ₹37.41 Lakh, a growth of 5% compared to the previous year. For the same year it recorded a net loss of ₹5,616 (net margin -0.2%) and EBITDA of ₹24,928 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company Details of Claro Pharmaceuticals Private Limited
CIN U24232TG2011PTC073540
Registration Number 073540
Incorporation Date 28 March 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 December 2020
Date of Balance Sheet 31 March 2020
Compliance Status Active Compliant
Key People
Arun Singh Additional Director Chevuru Komaleswari Additional Director Chevuru Hariprasad Director
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    16 – 2 – 753/1/192 Konark Towers Flat No. 405 Gaddi Annaram, Hyderabad, Telangana, India – 500035
  • Industry
    Healthcare, Medical & Laboratory Equipment
Comprehensive company report
Claro Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Claro Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Claro Pharmaceuticals Private Limited in one report.

Financials from 2015 Directors & ownership Charges & compliance

CIN History of Claro Pharmaceuticals Private Limited

Claro Pharmaceuticals has one previous CIN (Corporate Identification Number): U24232AP2011PTC073540. The current CIN is U24232TG2011PTC073540, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24232TG2011PTC073540Current
U24232AP2011PTC073540Previous

Business Activity of Claro Pharmaceuticals Private Limited

The main business activity of Claro Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
QHospital and Medical CareQ6Other Hospital and Medical Care ActivitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Claro Pharmaceuticals Private Limited

Claro Pharmaceuticals Private Limited is audited by MANORANJAN REDDY AND ASSOCIATES for the financial year 2019.

NameStatusAppointment DateCessation Date
MANORANJAN REDDY AND ASSOCIATESLockedLockedLocked
Premium access

Complete auditor history

Appointment and cessation dates and past auditor changes are in the company report.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Claro Pharmaceuticals Private Limited

Claro Pharmaceuticals has 3 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Arun Singh
Also directs: Arsa Life Care Private Limited
Additional Director21 Mar 20224 Years 6 MonthsCurrent
Chevuru KomaleswariAdditional Director09 Jan 201412 Years 8 MonthsCurrent
Chevuru HariprasadDirector16 Jul 201412 Years 2 MonthsCurrent
View all directors

Financials of Claro Pharmaceuticals Private Limited FY 2020 filings available

Claro Pharmaceuticals Private Limited reported revenue of ₹37.41 Lakh (up 5% YoY) for FY 2020.

Revenue · FY 2020
₹37.41 Lakh ▲ 5%
Net loss · FY 2020
₹5,616 margin -0.2%
EBITDA · FY 2020
₹24,928 margin 0.7%

Compounded Annual Growth Rate (CAGR) of Claro Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 10%
5 years · compounded
▲ 7%
EBITDA CAGR growth
1 year
▼ 68%
3 years · compounded
▼ 31%
5 years · compounded
▲ 18%

Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 5% growth in the latest year. EBITDA fell 68% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary of Claro Pharmaceuticals Private Limited

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profit and Loss Statement
Revenue from Operations₹37.41 Lakh••••••••••••••••
Other Income••••••••••••••••••••
Total Revenue••••••••••••••••••••
Cost of Materials Consumed••••••••••••••••••••
Employee Benefit Expense••••••••••••••••••••
Finance Costs••••••••••••••••••••
Depreciation and Amortisation••••••••••••••••••••
Other Expenses••••••••••••••••••••
Total Expenses••••••••••••••••••••
EBITDA₹24,928••••••••••••••••
Profit Before Tax••••••••••••••••••••
Tax Expense••••••••••••••••••••
Net Profit (PAT)-₹5,616••••••••••••••••
Balance Sheet
Share Capital••••••••••••••••••••
Reserves and Surplus••••••••••••••••••••
Net Worth (Total Equity)••••••••••••••••••••
Long-term Borrowings••••••••••••••••••••
Short-term Borrowings••••••••••••••••••••
Trade Payables••••••••••••••••••••
Total Liabilities••••••••••••••••••••
Fixed Assets••••••••••••••••••••
Investments••••••••••••••••••••
Inventories••••••••••••••••••••
Trade Receivables••••••••••••••••••••
Cash and Bank Balance••••••••••••••••••••
Total Assets••••••••••••••••••••

Financial Ratios of Claro Pharmaceuticals Private Limited

MetricsFY 2019-20FY 2018-19FY 2017-18FY 2016-17FY 2015-16
Profitability
EBITDA Margin0.7%••••••••••••••••
Net Profit Margin-0.2%••••••••••••••••
Return on Equity (ROE)••••••••••••••••••••
Return on Capital Employed (ROCE)••••••••••••••••••••
Return on Assets (ROA)••••••••••••••••••••
Liquidity and Debt
Current Ratio••••••••••••••••••••
Quick Ratio••••••••••••••••••••
Debt-to-Equity Ratio••••••••••••••••••••
Interest Coverage Ratio••••••••••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••••••••••
Receivable Days••••••••••••••••••••
Payable Days••••••••••••••••••••
Inventory Days••••••••••••••••••••
Revenue Growth••••••••••••••••••••
Net Profit Growth••••••••••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Claro Pharmaceuticals are in the company report.

Premium access

Financial statements from 2015

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Claro Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data

Promoter, institutional, public and beneficial ownership figures are in the company report.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Claro Pharmaceuticals Private Limited

Claro Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Claro Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Claro Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Claro Pharmaceuticals Private Limited

Claro Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
36AAECC4747M1ZATelanganaActive01 Jul 2017
Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Claro Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Claro Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Claro Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Claro Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Claro Pharmaceuticals Private Limited

Directors
21 Mar 2022
Arun Singh was appointed as a Additional Director on 21 Mar 2022 & has been associated with this company since 4 years 6 months.
Activity
31 Dec 2020
Claro Pharmaceuticals Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records.
Activity
31 Mar 2020
Claro Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Hyderabad.
Directors
16 Jul 2014
Chevuru Hariprasad was appointed as a Director on 16 Jul 2014 & has been associated with this company since 12 years 2 months.
Directors
09 Jan 2014
Chevuru Komaleswari was appointed as a Additional Director on 09 Jan 2014 & has been associated with this company since 12 years 8 months.
Activity
28 Mar 2011
Claro Pharmaceuticals Private Limited was registered on 28 Mar 2011 with Roc Hyderabad & aged 15 years 6 months as per MCA records.

Frequently Asked Questions about Claro Pharmaceuticals Private Limited

Claro Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 28 March 2011 (15+ years old) and is registered under CIN U24232TG2011PTC073540.

Claro Pharmaceuticals reported revenue of ₹37.41 Lakh for FY 2020 (up 5% YoY).

Claro Pharmaceuticals has 3 current directors:

Claro Pharmaceuticals reported a net loss of ₹5,616 (net margin -0.2%) and EBITDA of ₹24,928 (EBITDA margin 0.7%) for FY 2020, as per its filed financial statements.

The compounded annual growth rate (CAGR) of the revenue of Claro Pharmaceuticals is 10% over three years and 7% over five years. In the latest year (FY 2020) revenue rose 5%. CAGR is the steady yearly rate that links the first and the last year.

The GSTIN of Claro Pharmaceuticals is 36AAECC4747M1ZA, registered in Telangana.

The CIN (Corporate Identification Number) of Claro Pharmaceuticals is U24232TG2011PTC073540. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Claro Pharmaceuticals was incorporated on 28 March 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.

The registered office of Claro Pharmaceuticals is at 16 – 2 – 7531192 Konark Towers Flat No. 405 Gaddi Annaram, Hyderabad, Telangana, India – 500035.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available